Home/Filings/4/0001628908-25-000038
4//SEC Filing

KECK KIM 4

Accession 0001628908-25-000038

CIK 0001628908other

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 8:04 AM ET

Size

5.2 KB

Accession

0001628908-25-000038

Insider Transaction Report

Form 4
Period: 2025-03-07
KECK KIM
Director
Transactions
  • Purchase

    Class A Common Stock

    2025-03-07$9.44/sh+10,540$99,49839,522 total
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.09-$9.47, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001818332

Filing Metadata

Form type
4
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 8:04 AM ET
Size
5.2 KB